Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EYPT | ABVX | HUMA | ||
| Company | Eyepoint Pharmaceuticals Inc | Abivax Sa ADR | Humacyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.88 | 10.36 | 5.12 | ||
| High | 12.47 | 10.40 | 5.58 | ||
| Low | 11.31 | 10.21 | 5.12 | ||
| Last | 12.06 | 10.27 | 5.39 | ||
| Change | +0.30 | -0.05 | +0.34 | ||
| % Change | +2.55% | -0.48% | +6.73% | ||
| Volume | 839,200 | 259,200 | 3,180,700 | ||
| 20-Day Average Volume | 1,071,995 | 185,700 | 3,094,010 | ||
| Previous Close | 11.76 | 10.32 | 5.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.28 | 10.04 | 5.45 | ||
| 20-Day Raw Stochastic | 67.43% | 68.78% | 48.61% | ||
| 20-Day Relative Strength | 63.84% | 45.33% | 47.61% | ||
| Weighted Alpha | -22.71 | -11.43 | +73.02 | ||
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | ||
| Previous Opinion | 24% Buy | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.95% since 10/25/24 | -0.29% since 10/25/24 | -3.58% since 10/25/24 | ||
| Low | 10.35 on 10/28/24 | 10.21 on 11/01/24 | 4.85 on 10/31/24 | ||
| High | 13.98 on 10/28/24 | 10.96 on 10/29/24 | 5.63 on 10/28/24 | ||
| 1-Month | |||||
| %Chg | +50.75% since 10/01/24 | -6.38% since 10/01/24 | -1.91% since 10/01/24 | ||
| Low | 7.88 on 10/02/24 | 8.75 on 10/14/24 | 4.51 on 10/17/24 | ||
| High | 13.98 on 10/28/24 | 10.96 on 10/29/24 | 6.34 on 10/02/24 | ||
| 3-Month | |||||
| %Chg | +32.09% since 08/01/24 | -12.67% since 08/01/24 | -37.47% since 08/01/24 | ||
| Low | 7.40 on 08/14/24 | 8.75 on 10/14/24 | 4.51 on 10/17/24 | ||
| High | 13.98 on 10/28/24 | 13.17 on 08/30/24 | 8.72 on 08/07/24 | ||
| 6-Month | |||||
| %Chg | -33.15% since 05/01/24 | -31.72% since 05/01/24 | +22.50% since 05/01/24 | ||
| Low | 7.40 on 08/14/24 | 8.75 on 10/14/24 | 4.28 on 05/02/24 | ||
| High | 21.25 on 05/03/24 | 15.10 on 05/03/24 | 9.97 on 05/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 645,427 | 650,040 | 643,302 | ||
| Shares Outstanding, K | 53,518 | 63,295 | 119,351 | ||
| Annual Sales | 46,020,000 | 0 | 0 | ||
| Annual Net Income | -70,800,000 | -159,900,000 | -110,780,000 | ||
| Last Quarter Sales | 9,480,000 | N/A | 0 | ||
| Last Quarter Net Income | -30,830,000 | N/A | -56,660,000 | ||
| 60-Month Beta | 1.50 | N/A | 1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 08/07/24 | N/A | -0.27 on 08/13/24 | ||
| Latest Earnings Date | 11/06/24 | N/A | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||